Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin G Sanda

Showing results (71-80 of 180) with videos related to

Pageof 18
Sort By:
Cancer|March 11, 2003
Use of quality indicators to evaluate the care of patients with localized prostate carcinomaDavid C Miller, Mark S Litwin, Martin G Sanda, et al.
The Journal of Urology|September 28, 2011
Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health StudyJulie L Kasperzyk, William V Shappley, Stacey A Kenfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancerJohn T Wei, Rodney L Dunn, Howard M Sandler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2003
The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancerRainer Kuefer, Matthias D Hofer, Juergen E Gschwend, et al.
Practical Radiation Oncology|June 25, 2018
Predicting erectile function following external beam radiation therapy or brachytherapy for prostate cancer using EPIC-CPStephen A Mihalcik, Jonathan J Chipman, Martin G Sanda, et al.
Urology|July 18, 2006
Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifferenceDavid C Miller, John T Wei, Rodney L Dunn, et al.
Cancer|October 19, 2011
Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention TrialStephen B Williams, Simpa Salami, Meredith M Regan, et al.
Urology|February 22, 2019
Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life After Treatment for Localized Prostate CancerDavid J Einstein, Dattatraya Patil, Jonathan Chipman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapyDavid C Miller, Martin G Sanda, Rodney L Dunn, et al.
The Journal of Urology|October 1, 2013
Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practiceJonathan J Chipman, Martin G Sanda, Rodney L Dunn, et al.
Pageof 18

Showing results (71-80 of 180) with videos related to

Sort By:
Pageof 18
Cancer|March 11, 2003
Use of quality indicators to evaluate the care of patients with localized prostate carcinomaDavid C Miller, Mark S Litwin, Martin G Sanda, et al.
The Journal of Urology|September 28, 2011
Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health StudyJulie L Kasperzyk, William V Shappley, Stacey A Kenfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancerJohn T Wei, Rodney L Dunn, Howard M Sandler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2003
The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancerRainer Kuefer, Matthias D Hofer, Juergen E Gschwend, et al.
Practical Radiation Oncology|June 25, 2018
Predicting erectile function following external beam radiation therapy or brachytherapy for prostate cancer using EPIC-CPStephen A Mihalcik, Jonathan J Chipman, Martin G Sanda, et al.
Urology|July 18, 2006
Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifferenceDavid C Miller, John T Wei, Rodney L Dunn, et al.
Cancer|October 19, 2011
Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention TrialStephen B Williams, Simpa Salami, Meredith M Regan, et al.
Urology|February 22, 2019
Expanded Prostate Cancer Index Composite-26 (EPIC-26) Online: Validation of an Internet-Based Instrument for Assessment of Health-Related Quality of Life After Treatment for Localized Prostate CancerDavid J Einstein, Dattatraya Patil, Jonathan Chipman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapyDavid C Miller, Martin G Sanda, Rodney L Dunn, et al.
The Journal of Urology|October 1, 2013
Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practiceJonathan J Chipman, Martin G Sanda, Rodney L Dunn, et al.
Pageof 18